Clinical trial
A Multicenter, Open-label, Randomized, Bupivacaine-Controlled Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Aged 0 to Less Than 6 Years Undergoing Cardiac Surgery
NCT06271265 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-label, Randomized, Bupivacaine-Controlled Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Aged 0 to Less Than 6 Years Undergoing Cardiac Surgery
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 29, 2024
- Completion date
- January 31, 2027
- Enrollment
- 48 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.